2-[5,5-dimethyl-3-[(E)-2-(25,26,27,28-tetrapropoxy-5-pentacyclo[19.3.1.13,7.19,13.115,19]octacosa-1(24),3,5,7(28),9,11,13(27),15(26),16,18,21(25),22-dodecaenyl)ethenyl]cyclohex-2-en-1-ylidene]propanedinitrile

C53H60N2O4 — CID 10676748

IUPAC2-[5,5-dimethyl-3-[(E)-2-(25,26,27,28-tetrapropoxy-5-pentacyclo[19.3.1.13,7.19,13.115,19]octacosa-1(24),3,5,7(28),9,11,13(27),15(26),16,18,21(25),22-dodecaenyl)ethenyl]cyclohex-2-en-1-ylidene]propanedinitrile
SMILESCCCOc1c2cccc1Cc1cccc(c1OCCC)Cc1cc(/C=C/C3=CC(=C(C#N)C#N)CC(C)(C)C3)cc(c1OCCC)Cc1cccc(c1OCCC)C2
InChIInChI=1S/C53H60N2O4/c1-7-22-56-49-39-14-11-15-40(49)30-42-17-13-19-44(51(42)58-24-9-3)32-46-27-37(20-21-38-28-47(48(35-54)36-55)34-53(5,6)33-38)26-45(52(46)59-25-10-4)31-43-18-12-16-41(29-39)50(43)57-23-8-2/h11-21,26-28H,7-10,22-25,29-34H2,1-6H3/b21-20+
InChIKeyPGQKIVZZUHRDFB-QZQOTICOSA-N
MW789.07 g/mol
LogP12.62
Rot. Bonds14

About 2-[5,5-dimethyl-3-[(E)-2-(25,26,27,28-tetrapropoxy-5-pentacyclo[19.3.1.13,7.19,13.115,19]octacosa-1(24),3,5,7(28),9,11,13(27),15(26),16,18,21(25),22-dodecaenyl)ethenyl]cyclohex-2-en-1-ylidene]propanedinitrile

2-[5,5-dimethyl-3-[(E)-2-(25,26,27,28-tetrapropoxy-5-pentacyclo[19.3.1.13,7.19,13.115,19]octacosa-1(24),3,5,7(28),9,11,13(27),15(26),16,18,21(25),22-dodecaenyl)ethenyl]cyclohex-2-en-1-ylidene]propanedinitrile (PubChem CID 10676748) has the molecular formula C53H60N2O4 and a molecular weight of 789.07 g/mol. Its IUPAC name is 2-[5,5-dimethyl-3-[(E)-2-(25,26,27,28-tetrapropoxy-5-pentacyclo[19.3.1.13,7.19,13.115,19]octacosa-1(24),3,5,7(28),9,11,13(27),15(26),16,18,21(25),22-dodecaenyl)ethenyl]cyclohex-2-en-1-ylidene]propanedinitrile.

Molecular Properties

Compound Name2-[5,5-dimethyl-3-[(E)-2-(25,26,27,28-tetrapropoxy-5-pentacyclo[19.3.1.13,7.19,13.115,19]octacosa-1(24),3,5,7(28),9,11,13(27),15(26),16,18,21(25),22-dodecaenyl)ethenyl]cyclohex-2-en-1-ylidene]propanedinitrile
PubChem CID10676748
Molecular FormulaC53H60N2O4
Molecular Weight789.07 g/mol
Exact Mass788.46
IUPAC Name2-[5,5-dimethyl-3-[(E)-2-(25,26,27,28-tetrapropoxy-5-pentacyclo[19.3.1.13,7.19,13.115,19]octacosa-1(24),3,5,7(28),9,11,13(27),15(26),16,18,21(25),22-dodecaenyl)ethenyl]cyclohex-2-en-1-ylidene]propanedinitrile
SMILESCCCOc1c2cccc1Cc1cccc(c1OCCC)Cc1cc(/C=C/C3=CC(=C(C#N)C#N)CC(C)(C)C3)cc(c1OCCC)Cc1cccc(c1OCCC)C2
InChIInChI=1S/C53H60N2O4/c1-7-22-56-49-39-14-11-15-40(49)30-42-17-13-19-44(51(42)58-24-9-3)32-46-27-37(20-21-38-28-47(48(35-54)36-55)34-53(5,6)33-38)26-45(52(46)59-25-10-4)31-43-18-12-16-41(29-39)50(43)57-23-8-2/h11-21,26-28H,7-10,22-25,29-34H2,1-6H3/b21-20+
InChIKeyPGQKIVZZUHRDFB-QZQOTICOSA-N
XLogP12.62
TPSA84.50 Ų
H-Bond Donors
H-Bond Acceptors6
Rotatable Bonds14
Heavy Atoms59
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500789.07
LogP ≤ 512.62
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'conjugated_nitrile_group', 'substructure': 'N/A'}

Analyze 2-[5,5-dimethyl-3-[(E)-2-(25,26,27,28-tetrapropoxy-5-pentacyclo[19.3.1.13,7.19,13.115,19]octacosa-1(24),3,5,7(28),9,11,13(27),15(26),16,18,21(25),22-dodecaenyl)ethenyl]cyclohex-2-en-1-ylidene]propanedinitrile with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[5,5-dimethyl-3-[(E)-2-(25,26,27,28-tetrapropoxy-5-pentacyclo[19.3.1.13,7.19,13.115,19]octacosa-1(24),3,5,7(28),9,11,13(27),15(26),16,18,21(25),22-dodecaenyl)ethenyl]cyclohex-2-en-1-ylidene]propanedinitrile?
The IUPAC name of 2-[5,5-dimethyl-3-[(E)-2-(25,26,27,28-tetrapropoxy-5-pentacyclo[19.3.1.13,7.19,13.115,19]octacosa-1(24),3,5,7(28),9,11,13(27),15(26),16,18,21(25),22-dodecaenyl)ethenyl]cyclohex-2-en-1-ylidene]propanedinitrile (CID 10676748) is 2-[5,5-dimethyl-3-[(E)-2-(25,26,27,28-tetrapropoxy-5-pentacyclo[19.3.1.13,7.19,13.115,19]octacosa-1(24),3,5,7(28),9,11,13(27),15(26),16,18,21(25),22-dodecaenyl)ethenyl]cyclohex-2-en-1-ylidene]propanedinitrile.
What is the SMILES notation for 2-[5,5-dimethyl-3-[(E)-2-(25,26,27,28-tetrapropoxy-5-pentacyclo[19.3.1.13,7.19,13.115,19]octacosa-1(24),3,5,7(28),9,11,13(27),15(26),16,18,21(25),22-dodecaenyl)ethenyl]cyclohex-2-en-1-ylidene]propanedinitrile?
The canonical SMILES for 2-[5,5-dimethyl-3-[(E)-2-(25,26,27,28-tetrapropoxy-5-pentacyclo[19.3.1.13,7.19,13.115,19]octacosa-1(24),3,5,7(28),9,11,13(27),15(26),16,18,21(25),22-dodecaenyl)ethenyl]cyclohex-2-en-1-ylidene]propanedinitrile is CCCOc1c2cccc1Cc1cccc(c1OCCC)Cc1cc(/C=C/C3=CC(=C(C#N)C#N)CC(C)(C)C3)cc(c1OCCC)Cc1cccc(c1OCCC)C2.
What is the InChIKey of 2-[5,5-dimethyl-3-[(E)-2-(25,26,27,28-tetrapropoxy-5-pentacyclo[19.3.1.13,7.19,13.115,19]octacosa-1(24),3,5,7(28),9,11,13(27),15(26),16,18,21(25),22-dodecaenyl)ethenyl]cyclohex-2-en-1-ylidene]propanedinitrile?
The InChIKey is PGQKIVZZUHRDFB-QZQOTICOSA-N. The full InChI is InChI=1S/C53H60N2O4/c1-7-22-56-49-39-14-11-15-40(49)30-42-17-13-19-44(51(42)58-24-9-3)32-46-27-37(20-21-38-28-47(48(35-54)36-55)34-53(5,6)33-38)26-45(52(46)59-25-10-4)31-43-18-12-16-41(29-39)50(43)57-23-8-2/h11-21,26-28H,7-10,22-25,29-34H2,1-6H3/b21-20+.
What are the key properties of 2-[5,5-dimethyl-3-[(E)-2-(25,26,27,28-tetrapropoxy-5-pentacyclo[19.3.1.13,7.19,13.115,19]octacosa-1(24),3,5,7(28),9,11,13(27),15(26),16,18,21(25),22-dodecaenyl)ethenyl]cyclohex-2-en-1-ylidene]propanedinitrile?
2-[5,5-dimethyl-3-[(E)-2-(25,26,27,28-tetrapropoxy-5-pentacyclo[19.3.1.13,7.19,13.115,19]octacosa-1(24),3,5,7(28),9,11,13(27),15(26),16,18,21(25),22-dodecaenyl)ethenyl]cyclohex-2-en-1-ylidene]propanedinitrile has a molecular weight of 789.07 g/mol, XLogP of 12.62, 14 rotatable bonds, 0 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[5,5-dimethyl-3-[(E)-2-(25,26,27,28-tetrapropoxy-5-pentacyclo[19.3.1.13,7.19,13.115,19]octacosa-1(24),3,5,7(28),9,11,13(27),15(26),16,18,21(25),22-dodecaenyl)ethenyl]cyclohex-2-en-1-ylidene]propanedinitrile is sourced from PubChem (CID 10676748), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).